Advertisement
 

Oregon Biotech Company Receives OK to Sell Shares

May 12, 1989|United Press International

BEAVERTON, Ore. — Epitope Inc. announced that the Securities and Exchange Commission has approved its sale of 1.25 million shares of common stock at $5 each.

Shares in the biotechnology company are being sold to a limited number of U.S. and European institutional and other qualified investors, officials said. Sutro & Co. of San Francisco is the underwriter for the stock offering.

Net proceeds from the offering will be used in development of new diagnostic tests for AIDS, therapeutic drugs for malaria, antiviral barriers and novel plant varieties, as well as general corporate purposes, Epitope officials said.

Advertisement
Los Angeles Times Articles
|
|
|